MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor- β (TGF-β) Signaling Pathway.

CONCLUSIONS These findings indicated that miR-181c suppressed osteosarcoma progression, providing new insight into the pathogenesis and representing a potential therapeutic target for osteosarcoma.
PMID: 31251735 [PubMed - in process]

Source: Medical Science Monitor - July 1, 2019 Category: Research Tags: Med Sci Monit Source Type: research